Landmark BioVentures
- Biotech or pharma, therapeutic R&D
Landmark BioVentures is an integrative corporate and drug development engine with a unique model focused on lean operations, smart resource allocation, and co-founding a diversified yet complementary nexus of 7 biotech companies developing first-in-class therapeutics from Iate preclinical to clinical stage (Oncology, Immunology, Fibrosis, Ophtalmology).
We pursue partnerships, M&A, and funding opportunities for Landmark's portfolio companies as well as strategic collaborations within our core focus areas.